300313 ST天山生物
按盤價 
6.780 -0.330 (-4.641%)
6.780 -0.330 (-4.641%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -100.670 | -30.069 | -33.810 | -21.075 | 2.770 |
| 總資產報酬率 ROA (%) | -14.118 | -6.793 | -8.700 | -4.180 | 0.411 |
| 投入資產回報率 ROIC (%) | -31.633 | -13.037 | -14.583 | -8.625 | 1.487 | 邊際利潤分析 |
| 銷售毛利率 (%) | -2.278 | 16.986 | 14.166 | 7.089 | 15.772 |
| 營業利潤率 (%) | -33.509 | -13.572 | -36.988 | -26.047 | -4.878 |
| 息稅前利潤/營業總收入 (%) | -27.969 | -6.278 | -21.879 | -13.434 | 9.318 |
| 淨利潤/營業總收入 (%) | -38.508 | -16.061 | -41.952 | -28.149 | 1.538 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 78.271 | 80.289 | 73.521 | 117.534 | -529.547 |
| 價值變動淨收益/利潤總額(%) | -7.045 | -15.069 | 26.411 | -2.921 | 225.351 |
| 營業外收支淨額/利潤總額(%) | 5.855 | 3.340 | 7.324 | 1.479 | 340.526 | 償債能力分析 |
| 流動比率 (X) | 0.376 | 0.484 | 0.521 | 0.633 | 0.100 |
| 速動比率 (X) | 0.197 | 0.168 | 0.281 | 0.527 | 0.039 |
| 資產負債率 (%) | 88.405 | 77.162 | 71.714 | 71.353 | 83.565 |
| 帶息債務/全部投入資本 (%) | 64.429 | 50.434 | 47.535 | 53.899 | -- |
| 股東權益/帶息債務 (%) | 28.870 | 80.674 | 95.850 | 76.713 | 72.425 |
| 股東權益/負債合計 (%) | 8.462 | 25.559 | 35.290 | 36.558 | 20.446 |
| 利息保障倍數 (X) | -3.669 | -0.809 | -1.213 | -1.033 | 1.278 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 39.925 | 25.984 | 82.715 | 61.330 | 0.000 |
| 存貨周轉天數 (天) | 134.930 | 199.698 | 228.050 | 133.930 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
